MarketRIG-I
Company Profile

RIG-I

RIG-I is a cytosolic pattern recognition receptor (PRR) that can mediate induction of a type-I interferon (IFN1) response. RIG-I is an essential molecule in the innate immune system for recognizing cells that have been infected with a virus. These viruses can include West Nile virus, Japanese Encephalitis virus, influenza A, Sendai virus, flavivirus, and coronaviruses.

Structure
RIG-I is encoded by the DDX58 gene in humans. RIG-I is a helical ATP-dependent DExD/H box RNA helicase with a repressor domain (RD) on the C-terminus that binds to the target RNA. == Functions ==
Functions
As a pattern recognition receptor Pattern recognition receptors Pattern recognition receptors (PRRs) are a part of the innate immune system used for recognizing invaders. In a viral infection, a virus enters a cell, and it takes over the cell's machinery to self replicate. Once a virus has begun replication, the infected cell is no longer useful and potentially harmful to its host, and the host's immune system must be notified. RIG-I functions as a pattern recognition receptor and PRR's are the molecules that start the notification process. PRRs recognize specific pathogen-associated molecular patterns (PAMP). It is important to note, however, that the ligands of RIG-I are still being investigated and are controversial. Also notable, is that RIG-I can work together with MDA5 against viruses that RIG-I itself may not create a significant enough response. In vitro transcribed RNAs initiated with 5′-triphosphorylated adenosine generate significantly greater levels of highly immunogenic dsRNAs, compared to their 5′-triphosphorylated guanosine counterparts. Type-1 interferon pathway RIG-I is a signaling molecule and is usually in a condensed resting state until it is activated. Once RIG-I is bound to its PAMP, molecules such as PACT and zinc antiviral protein short isoform (ZAPs), help keep RIG-I in an activated state which then keeps the caspase activation and recruitment domains (CARDs) ready for binding. == Identification and naming ==
Identification and naming
In 2000, RIG-I was named by researchers from the Shanghai Institute of Hematology who identified novel genes that respond to all-trans retinoic acid (ATRA) in leukemia cells. RIG-I and the other genes were assigned the temporary name of RIG (retinoic acid–induced gene) in the format of RIG-A, RIG-B etc by the group, however they performed no additional characterization on RIG-I. == References ==
tickerdossier.comtickerdossier.substack.com